4//SEC Filing
Sagent Pharmaceuticals, Inc. 4
Accession 0001585283-13-000025
CIK 0001369786operating
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 1:11 PM ET
Size
12.7 KB
Accession
0001585283-13-000025
Insider Transaction Report
Form 4
Transactions
- Sale
common stock
2013-09-30$20.46/sh−28,872$590,828→ 3,894,139 total(indirect: see footnote (2) (3)) - Sale
common stock
2013-09-27$20.60/sh−10,000$206,000→ 3,923,011 total(indirect: see footnote (2) (3)) - Sale
common stock
2013-09-30$20.38/sh−25,000$509,615→ 3,869,139 total(indirect: see footnote (2) (3)) - Sale
common stock
2013-09-27$20.52/sh−31,300$642,188→ 3,933,011 total(indirect: see footnote (2) (3))
MORGAN STANLEY AIP GP LP
10% Owner
Transactions
- Sale
common stock
2013-09-27$20.52/sh−31,300$642,188→ 3,933,011 total(indirect: see footnote (2) (3)) - Sale
common stock
2013-09-27$20.60/sh−10,000$206,000→ 3,923,011 total(indirect: see footnote (2) (3)) - Sale
common stock
2013-09-30$20.38/sh−25,000$509,615→ 3,869,139 total(indirect: see footnote (2) (3)) - Sale
common stock
2013-09-30$20.46/sh−28,872$590,828→ 3,894,139 total(indirect: see footnote (2) (3))
Footnotes (3)
- [F1]Represents shares of Common Stock owned by certain funds (each, a "Fund" and collectively, the "Funds") and certain separately managed accounts managed by the undersigned.
- [F2]The shares reported are held of record by Stormlaunch & Co., Sailorshell & Co., Stormbay & Co., Stormstar & Co., Weyerhaeuser Company Master Retirement Trust, Sailerpier & Co., Factory Mutual Insurance Company and Nuclear Electric Insurance Limited.
- [F3]The reported securities are held directly by the Funds and certain separately managed accounts managed by each of the reporting persons. Morgan Stanley Investment Management Inc. ("MSIM") is the investment manager of one or more of the separately managed accounts and Morgan Stanley AIP GP LP ("AIP") is the investment manager of one or more of the Funds. This form is filed without prejudice to the reporting persons' position that none of the Funds nor any subsidiaries of the reporting persons, nor the reporting persons individually or in aggregate, are required to file beneficial ownership reports under Section 16(a) of the Securities Exchange Act of 1934, and should not be construed or interpreted as a concession or admission that such reports are required.
Documents
Issuer
Sagent Pharmaceuticals, Inc.
CIK 0001369786
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001369786
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 1:11 PM ET
- Size
- 12.7 KB